These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38903709)

  • 1. Immune cell related signature predicts prognosis in esophageal squamous cell carcinoma based on single-cell and bulk-RNA sequencing.
    Wang X; Peng W; Zhao Y; Sha J; Li N; Huang S; Wang H
    Front Oncol; 2024; 14():1370801. PubMed ID: 38903709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel immune-related gene signature predicts survival in esophageal squamous cell carcinoma.
    Xu T; Dai T; Zeng P; Guo Y; He K
    Transl Cancer Res; 2021 May; 10(5):2354-2367. PubMed ID: 35116551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
    Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
    Front Oncol; 2021; 11():769727. PubMed ID: 34926275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
    Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
    Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and verification of a hypoxia- and immune-associated prognosis signature for esophageal squamous cell carcinoma.
    Lian L; Teng SB; Xia YY; Shen XM; Zheng Y; Han SG; Wang WJ; Xu XF; Zhou C
    J Gastrointest Oncol; 2022 Apr; 13(2):462-477. PubMed ID: 35557566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of key genes for esophageal squamous cell carcinoma via integrated bioinformatics analysis and experimental confirmation.
    Hu J; Li R; Miao H; Wen Z
    J Thorac Dis; 2020 Jun; 12(6):3188-3199. PubMed ID: 32642240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
    Ren Q; Zhang P; Zhang X; Feng Y; Li L; Lin H; Yu Y
    Front Immunol; 2023; 14():1199040. PubMed ID: 37313409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer.
    Cao K; Ma T; Ling X; Liu M; Jiang X; Ma K; Zhu J; Ma J
    Ann Transl Med; 2021 Oct; 9(20):1591. PubMed ID: 34790797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma.
    Zhang D; Zhao F; Li J; Qin X; Li S; Niu R
    Aging (Albany NY); 2023 Aug; 15(15):7811-7830. PubMed ID: 37561524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of TRP Channel-Related Genes for Estimating the Immune Microenvironment, Prognosis, and Therapeutic Effect in Patients With Esophageal Squamous Cell Carcinoma.
    Zhao F; Gao S; Qin X; Niu R; Li Z; Wang C; Li S
    Front Cell Dev Biol; 2022; 10():820870. PubMed ID: 35309940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A more novel and robust gene signature predicts outcome in patients with esophageal squamous cell carcinoma.
    Ma C; Luo H
    Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102033. PubMed ID: 36265781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.
    Wang L; Wang L; He P
    Front Genet; 2022; 13():1064432. PubMed ID: 36568383
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of an immune-related gene signature for overall survival prediction and immune infiltration in gastric cancer.
    Ma XT; Liu X; Ou K; Yang L
    World J Gastrointest Oncol; 2024 Mar; 16(3):919-932. PubMed ID: 38577455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and Evaluation of a Risk Score Model for Lymph Node Metastasis-Associated Circadian Clock Genes in Esophageal Squamous Carcinoma.
    Cheng J; Chen F; Cheng Y
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.
    Qi X; Qi C; Qin B; Kang X; Hu Y; Han W
    Front Oncol; 2020; 10():541330. PubMed ID: 33072571
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Machine Learning Prognostic Model of m5C Related immune Genes in Lung Adenocarcinoma.
    Cao X; Ji Y; Li J; Liu Z; Chen C
    Cancer Control; 2024; 31():10732748241237414. PubMed ID: 38537151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.